Hanmi Pharmaceuticals Co Ltd - Company Profile
Powered by 
All the data and insights you need on Hanmi Pharmaceuticals Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Hanmi Pharmaceuticals Co Ltd Strategy Report
- Understand Hanmi Pharmaceuticals Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Hanmi Pharmaceuticals Co Ltd (Hanmi Pharmaceuticals) manufactures and sells medicines and pharmaceutical raw materials. The company classifies its products into over the counter (OTC) and ethical pharmaceuticals. Hanmi Pharmaceuticals reports its operations under three segments: Medicine, Drug Substance, and Overseas Medicines.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Hanmi Pharmaceuticals conducts research to develop its drug pipeline. The company conducts trials for its pipeline products in various phases targeting therapeutic areas such as oncology, obesity/metabolism, rare diseases, and other areas. The company is bolstering its pipeline through innovative platform technologies, including the Lapscoverytm platform for long-acting biologics, the Pentambodytm platform enabling a single antibody to interact with two targets, Cancer Research focusing on the development of mutation-driven targeted therapies, and IMD-New Formulation dedicated to fixed-dose combination programs. In FY2022, the company spent KRW154,316.7 million on its R&D activities. It also enters into partnership with other pharmaceutical companies for development and commercialization of its products.
Business Segments
Overview
Operates Drug Substance division through Hanmi Fine Chemicals Co Ltd. It’s a manufacturer and supplier of active pharmaceutical ingredients (APIs). Manufactures sterile cephalosporin APIs and oral cephalosporin APIs in one plant and general APIs in the other.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Offers over the counter (OTC) products and ethical pharmaceuticals. The OTC portfolio spans oral care, local anesthetics, myalgia, other central nervous system (CNS) medications, medications for hair growth, skeletal muscle relaxants, dandruff management, vitamins, nutritional supplements, constipation, digestive system, cardiovascular, ophthalmic diseases, hypnotics, gum disease treatment, probiotics, drugs for gum disease prevention, anti-diarrheal, cold medicine, anti-tussives, expectorant, iron supplement, calcium supplement, sinus cold, dermatology, contraceptive, antihistamines, and non-steroidal anti-inflammatory drugs (NSAIDS). The ethical pharmaceuticals include drugs for hepatitis, osteoarthritis, osteoporosis, epilepsy, oral care, smoking cessation aid, other CNS medications, nootropics, diabetes, immunosuppressant, urinogenital, anti-inflammatory, obesity, gastrointestinal, hypnotics, neuropathic pain, dermatology, prostatism, cardiovascular diseases, schizophrenia, ophthalmic diseases, expectorants, dementia, antitussives, antiemetics, Parkinson's disease, anti-cancer, antibiotics, anti-cancer therapy supple, antihistamines, antidepressant, muscle relaxants, and NSAIDs. Key brands include: Amosartan Family; Rosuzet; Pal Pal; Esomezol; Amodipin; Rovelito; Carnitil; Hanmi Tams; Naxozol; and Gugu.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Operates its Oversees division through Beijing Hanmi Pharmaceutical co. Ltd. It Focuses on the discovery and development of new chemical entities (NCEs) for the treatment of autoimmune diseases and cancer; new biologics for the treatment of diabetes, obesity, and cancer; and bioproduction of PENTAMBODY, a Penta amino acid mutated bispecific antibody. Flagship brands include Mami Ai, Itanjing, Mechangan, and Li Dong. Operates an animal facility for rodents, beagles, and primates; which holds high tech enterprise certification.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer